135
Participants
Start Date
February 1, 2017
Primary Completion Date
September 15, 2023
Study Completion Date
September 15, 2023
ADYNOVATE
Antihemophilic Factor (Recombinant), PEGylated
Nagoya City, Japan, Nagoya
Hirosaki City, Hirosaki
Chiba-City, Japan, Chiba
Matsudo City, Japan, Matsudo
Narita City, Narita
Matsuyama City, Japan, Matsuyama
Toon City, Tōon
Fukuoka-City, Japan, Fukuoka
Kitakyusyu City, Japan, Kitakyushu
Kitakyusyu City, Japan, Kitakyushu
Koriyama City, Kōriyama
Sukagawa City, Sukagawa
Ogaki City, Japan, Ōgaki
Maebashi City, Maebashi
Hiroshima City, Japan, Hiroshima
Kudou-Gun, Japan, Kudou-Gun
Sapporo City, Sapporo
Kobe City, Kobe
Kobe City, Kobe
Nishinomiya City, Japan, Nishinomiya
Morioka City, Japan, Morioka
Zentuji City, Japan, Zentuji City
Kagoshima City, Japan, Kagoshima
Kawasaki City, Japan, Kawasaki
Yokohama City, Japan, Yokohama
Yokohama City, Japan, Yokohama
Koti City, Japan, Kochi
Minamata City, Japan, Minamata
Kyoto City, Kyoto
Tsu City, Japan, Tsu
Sendai City, Sendai
Tome City, Japan, Tome
Nichinan City, Nichinan
Matsumoto City, Matsumoto
Nagano City, Japan, Nagano
Jyoetsu City, Jyoetsu City
Kashiwazaki City, Kashiwazaki
Kurasiki City, Japan, Kurashiki
Okayama City, Japan, Okayama
Higashiosaka City, Higashiosaka
Hirakata City, Hirakata
Nishi-ku, Nishi-ku
Osaka City, Japan, Osaka
Osaka-City, Japan, Osaka
Koshigaya City, Japan, Koshigaya
Saitama-City, Japan, Saitama
Tokushima City, Japan, Tokushima
Shinjuku-Ku, Japan, Shinjuku-Ku
Suginami-ku, Japan, Suginami-ku
Setagaya-ku, Japan, Setagaya-ku
Sakata City, Japan, Sakata
Shunan City, Japan, Shunan City
Lead Sponsor
Takeda
INDUSTRY